MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
331
Beneficiaries
—
Total drug cost
$149K
Distinct drugs
12
Brand share
13.0%
Top prescribed drugs
Leflunomide51 claims
Hydroxychloroquine Sulfate48 claims
Prednisone48 claims
Celecoxib33 claims
Tofacitinib Citrate24 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Andre Lallande's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 4 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Unilab Corporation Clinical Laboratory · West Hills, CA | 16 | 140 |
| RHEUMATOLOGY DIAGNOSTICS LABORATORY INC | 11 | 129 |
| SENAATI, SASSAN | 11 | 133 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| SENAATI, SASSAN | 34 | 742 |
| Al Franco Rheumatology · Riverside, CA | 33 | 611 |
| Unilab Corporation Clinical Laboratory · West Hills, CA | 32 | 430 |
| John Crues Diagnostic Radiology · Los Angeles, CA | 14 | 141 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE